Power saving glaucoma drainage device

• US 8,721,580 B2
• Filed: 07/16/2010
• Issued: 05/13/2014
• Est. Priority Date: 09/21/2009
• Status: Active Grant

• Current Assignee: Alcon Incorporated
• Original Assignee: Alcon Research Limited (Nestle SA)
• Inventors: Rickard, Matthew J. A., Sanchez, Robert Joseph Jr.
• Primary Examiner(s): Deak, Leslie R.
• Assistant Examiner(s): SASS, SARA A
• Application Number:
  US12/837,803
• Publication Number:
  US 20110071459A1
• Time in Patent Office: 1,397 Days
• Field of Search: 600/398, 600/561, 604/9, 604/540, 623/4.1, 128/903
• US Class Current: 604/9
• CPC Class Codes: A61F 9/00781 Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment drainage implants in general A61M27/002

Abstract

A glaucoma drainage device has an active valve configured to be located between an anterior chamber of an eye and a drainage location, a power source coupled to the active valve, and a controller coupled to the power source. A first pressure sensor is located in fluid communication with the anterior chamber, a second pressure sensor is located in the drainage location, and a third pressure sensor located remotely from the first and second pressure sensors. The controller reads the first, second, and third pressure sensors once during a period of time and adjusts the active valve to control intraocular pressure.

Claims

1. A glaucoma drainage device comprising:

an active valve configured to be located between an anterior chamber of an eye and a drainage location;

wherein the active valve comprises;

a housing with an open outlet end on a first end of the housing, and a needle head opening on a second end of the housing;

a tube in fluid communication with the open outlet end of the housing, the tube extending from the open outlet end of the housing;

an actuator located in the housing;

an actuation arm located at least partially in the housing, the actuation arm coupled to the actuator;

a tapered arm rigidly coupled to the actuation arm such that movement of the actuation arm results in movement of the tapered arm and the needle head, a tapered end of the tapered arm located at least partially in the tube; and

a needle head coupled to the actuation arm and the tapered arm, the needle head located opposite the tapered end of the tapered arm, the needle head located at least partially within the housing at the needle head opening of the housing;

a power source coupled to the active valve; and

a controller coupled to the power source;

wherein the controller directs power from the power source to the active valve based on a pressure.

2. The glaucoma drainage device of claim 1 wherein the pressure is intraocular pressure and the controller directs power from the power source to the active valve when the intraocular pressure is not in a range.

3. The glaucoma drainage device of claim 1 wherein the drainage location is selected from the group consisting of:

a subconjunctival space of the eye, a suprachoroidal space of the eye, a supraciliary space of the eye, a subscleral space of the eye, and outside the eye.

4. The glaucoma drainage device of claim 1 wherein the controller controls the position of the tapered arm so that it partially obstructs the tube thereby restricting fluid flow through the tube.

5. The glaucoma drainage device of claim 1 wherein the controller controls the actuator to move the needle head in a drainage location to disperse aqueous in the drainage location.

6. The glaucoma drainage device of claim 1 further comprising:

a first pressure sensor located in fluid communication with an anterior chamber of an eye; and

a second pressure sensor located in the drainage location;

wherein a difference between readings from the first pressure sensor and the second pressure sensor approximates a pressure differential between the anterior chamber and the drainage location; and

further wherein the controller uses the pressure differential to control the active valve.

7. The glaucoma drainage device of claim 4 further comprising;

a first pressure sensor located in fluid communication with an anterior chamber of an eye; and

a remote pressure sensor located remotely from the first pressure sensor such that the remote pressure sensor measures or approximates atmospheric pressure;

wherein a difference between readings from the first pressure sensor and the remote pressure sensor approximates intraocular pressure; and

further wherein the controller uses intraocular pressure to control the active valve.

8. An intraocular system comprising:

a first pressure sensor located in fluid communication with an anterior chamber of an eye;

a remote pressure sensor located remotely from the first pressure sensor such that the remote pressure sensor measures or approximates atmospheric pressure;

a barrier that separates the first pressure sensor from the remote pressure sensor;

a controller configured to read the first and second pressure sensors; and

a power source coupled to the controller; and

an active valve comprising;

a housing with an open outlet end on a first end of the housing, and a needle head opening on a second end of the housing;

a tube in fluid communication with the open outlet end of the housing, the tube extending from the open outlet end of the housing;

an actuation arm located at least partially in the housing, the actuation arm coupled to the actuator;

a tapered arm rigidly coupled to the actuation arm such that movement of the actuation arm results in movement of the tapered arm and the needle head, a tapered end of the tapered arm located at least partially in the tube; and

a needle head coupled to the actuation arm and the tapered arm, the needle head located opposite the tapered end of the tapered arm, the needle head located at least partially within the housing at the needle head opening of the housing;

wherein a difference between readings from the first pressure sensor and the remote pressure sensor approximates intraocular pressure; and

further wherein the first pressure sensor, the remote pressure sensor, and the barrier are all located on a single device implantable in the eye.